Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Cytological and epidemiological findings in trisomies 13, 18, and 21: England and Wales 2004-2009.

Alberman E, Mutton D, Morris JK.

Am J Med Genet A. 2012 May;158A(5):1145-50. doi: 10.1002/ajmg.a.35337. Epub 2012 Apr 11.

PMID:
22495937
2.

Cytogenetic and epidemiological findings in Down syndrome: England and Wales 1989-2009.

Morris JK, Alberman E, Mutton D, Jacobs P.

Am J Med Genet A. 2012 May;158A(5):1151-7. doi: 10.1002/ajmg.a.35248. Epub 2012 Mar 21.

PMID:
22438132
3.

Down's syndrome: screening and antenatal diagnosis regionally in England and Wales 1989-2008.

De Souza E, Alberman E, Morris JK.

J Med Screen. 2010;17(4):170-5. doi: 10.1258/jms.2010.010044.

PMID:
21258126
4.

Congenital malformations and the cerebral palsies - déjà vu, but now what?

Alberman E.

Dev Med Child Neurol. 2010 Apr;52(4):314-5. doi: 10.1111/j.1469-8749.2009.03482.x. Epub 2010 Jan 5. No abstract available.

6.

Down syndrome and paternal age, a new analysis of case-control data collected in the 1960s.

De Souza E, Alberman E, Morris JK.

Am J Med Genet A. 2009 Jun;149A(6):1205-8. doi: 10.1002/ajmg.a.32850.

PMID:
19449414
7.

Is the prevalence of Klinefelter syndrome increasing?

Morris JK, Alberman E, Scott C, Jacobs P.

Eur J Hum Genet. 2008 Feb;16(2):163-70. Epub 2007 Nov 14.

8.

Commentary on the revised versions of the definition and classification of cerebral palsy.

Alberman E, Mutch L.

Dev Med Child Neurol Suppl. 2007 Feb;109:32. No abstract available.

PMID:
17370478
9.
10.

Rates of Down syndrome at the upper extreme of maternal age: considerations and recommendations in analysis.

Morris JK, Mutton D, Alberman E.

Prenat Diagn. 2006 Nov;26(11):1091. No abstract available.

PMID:
17072886
11.

Maternal age-specific fetal loss rates in Down syndrome pregnancies.

Savva GM, Morris JK, Mutton DE, Alberman E.

Prenat Diagn. 2006 Jun;26(6):499-504.

PMID:
16634111
12.

Corrections to maternal age-specific live birth prevalence of Down's syndrome.

Morris J, Mutton D, Alberman E.

J Med Screen. 2005;12(4):202. No abstract available.

PMID:
16417698
13.

Cerebral palsy and perinatal exposure to neurotropic viruses.

Alberman E, Peckham C.

BMJ. 2006 Jan 14;332(7533):63-4. No abstract available.

14.

Recurrences of free trisomy 21: analysis of data from the National Down Syndrome Cytogenetic Register.

Morris JK, Mutton DE, Alberman E.

Prenat Diagn. 2005 Dec;25(12):1120-8.

PMID:
16231400
15.

Risk of a Down syndrome live birth in women 45 years of age and older.

Morris JK, De Vigan C, Mutton DE, Alberman E.

Prenat Diagn. 2005 Apr;25(4):275-8.

PMID:
15849789
16.

Triploidy identified through second-trimester serum screening.

Huang T, Alberman E, Wald N, Summers AM.

Prenat Diagn. 2005 Mar;25(3):229-33.

PMID:
15791661
17.

Prenatal screening for Down syndrome in England and Wales and population-based birth outcomes.

Smith-Bindman R, Chu P, Bacchetti P, Waters JJ, Mutton D, Alberman E.

Am J Obstet Gynecol. 2003 Oct;189(4):980-5.

PMID:
14586339
18.
19.

Using Down syndrome serum screening results to predict low birthweight.

Huang T, Alberman E, Watt HC, Wald NJ.

Prenat Diagn. 2003 May;23(5):420-6.

PMID:
12749041
20.

Comparison of models of maternal age-specific risk for Down syndrome live births.

Morris JK, Wald NJ, Mutton DE, Alberman E.

Prenat Diagn. 2003 Mar;23(3):252-8.

PMID:
12627430
21.

The National Down Syndrome Cytogenetic Register (NDSCR).

Alberman E.

J Med Screen. 2002;9(3):97-8. No abstract available.

PMID:
12370318
22.

Revised estimates of the maternal age specific live birth prevalence of Down's syndrome.

Morris JK, Mutton DE, Alberman E.

J Med Screen. 2002;9(1):2-6.

PMID:
11943789
23.

Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study.

Swerdlow AJ, Hermon C, Jacobs PA, Alberman E, Beral V, Daker M, Fordyce A, Youings S.

Ann Hum Genet. 2001 Mar;65(Pt 2):177-88. doi: 10.1017/S0003480001008569.

24.

Mortality and cancer incidence in persons with Down's syndrome, their parents and siblings.

Hermon C, Alberman E, Beral V, Swerdlow AJ.

Ann Hum Genet. 2001 Mar;65(Pt 2):167-76. doi: 10.1017/S0003480001008508.

25.

Birth events and cerebral palsy: facts were not presented clearly.

Stanley F, Blair E, Alberman E.

BMJ. 2001 Jan 6;322(7277):50. No abstract available.

26.

Adult cardiovascular risk factors in premature babies.

Hennessy E, Alberman E.

Lancet. 2000 Sep 9;356(9233):938-9. No abstract available.

PMID:
11036914
27.

Socioeconomic inequalities in risk of congenital anomaly.

Vrijheid M, Dolk H, Stone D, Abramsky L, Alberman E, Scott JE.

Arch Dis Child. 2000 May;82(5):349-52.

28.

National Confidential Enquiry into counselling for genetic disorders by non-geneticists: general recommendations and specific standards for improving care.

Harris R, Lane B, Harris H, Williamson P, Dodge J, Modell B, Ponder B, Rodeck C, Alberman E.

Br J Obstet Gynaecol. 1999 Jul;106(7):658-63.

PMID:
10428521
29.

Commentary: food should be fortified with folic acid.

Alberman E, Noble JM.

BMJ. 1999 Jul 10;319(7202):93. No abstract available.

30.

Birth prevalence of Down's syndrome in England and Wales 1990 to 1997.

Huang T, Watt H, Wald N, Morris J, Mutton D, Alberman E, Kelekun C.

J Med Screen. 1998;5(4):213-4. No abstract available.

PMID:
9934653
31.

Bibliography of Neville Butler.

Alberman E.

Paediatr Perinat Epidemiol. 1998 Jul;12 Suppl 1:6-14. No abstract available.

PMID:
9758561
32.

Trends in prenatal screening for and diagnosis of Down's syndrome: England and Wales, 1989-97.

Mutton D, Ide RG, Alberman E.

BMJ. 1998 Oct 3;317(7163):922-3. No abstract available.

33.

Is there evidence of clustering in Down syndrome?

Morris JK, Alberman E, Mutton D.

Int J Epidemiol. 1998 Jun;27(3):495-8.

PMID:
9698142
34.
35.
36.

Neville Butler and the British Birth Cohort studies. Foreword.

Bynner J, Goldstein H, Alberman E.

Paediatr Perinat Epidemiol. 1998 Jul;12 Suppl 1:1-5. No abstract available.

PMID:
9690270
37.

Survival in cerebral palsy: the role of severity and diagnostic labels.

Williams K, Alberman E.

Dev Med Child Neurol. 1998 Jun;40(6):376-9.

38.

Monitoring fetal and infant survival using regional birth notification data in north east London.

Hilder L, Alberman E.

J Epidemiol Community Health. 1998 Apr;52(4):253-8.

39.

The impact of diagnostic labelling in population-based research into cerebral palsy.

Williams K, Alberman E.

Dev Med Child Neurol. 1998 Mar;40(3):182-5.

40.
41.

The effects of own fetal growth on reported hypertension in parous women aged 33.

Hennessy E, Alberman E.

Int J Epidemiol. 1997 Jun;26(3):562-70.

PMID:
9222781
42.

Recommendations for improving national data on congenital anomalies are being implemented.

Alberman E, Botting B.

BMJ. 1997 Apr 26;314(7089):1278. No abstract available.

43.

Reliability of statistics on Down's syndrome notifications.

Huang T, Watt HC, Wald NJ, Morris JK, Mutton D, Alberman E.

J Med Screen. 1997;4(2):95-7.

PMID:
9275267
44.
45.

Cerebral palsy: effects of twinning, birthweight, and gestational age.

Williams K, Hennessy E, Alberman E.

Arch Dis Child Fetal Neonatal Ed. 1996 Nov;75(3):F178-82.

47.

Recent advances in obstetrics. Figures on screening for Down's syndrome are inaccurate.

Kennard A, Alberman E, Gill M.

BMJ. 1996 Feb 10;312(7027):379. No abstract available.

48.
49.

A twin study of congenital hemiplegia.

Goodman R, Alberman E.

Dev Med Child Neurol. 1996 Jan;38(1):3-12.

PMID:
8606014
50.

The natural history of Down syndrome conceptuses diagnosed prenatally that are not electively terminated.

Hook EB, Mutton DE, Ide R, Alberman E, Bobrow M.

Am J Hum Genet. 1995 Oct;57(4):875-81.

Supplemental Content

Loading ...
Support Center